Sunday, 27 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Acutaas Chemicals Earnings Call: Key Takeaways

Acutaas Chemicals reported strong Q4FY26 results with 40.3% YoY revenue growth and record PAT margins of 31%. Strategy focuses on Battery Chemicals, Semiconductors, and Pharma CDMO.

Why this was an Alfa AlertNot a filter event. While results were record-breaking, they were not explicitly compared against a prior guided range to confirm a 5%+ beat.
Highlights
Revenue growth43.3% YoY in Q4FY26; 33.0% YoY in FY26.
MarginsEBITDA margin expanded significantly to 35.9% in FY26 from 23.0%.
Demand visibilityStrong CDMO ramp-up and recovery in semiconductor business (BFC).
Management confidenceHigh; confident in delivering 25% revenue growth for FY27.

Growth

FY26 revenue grew 33% YoY to ₹13,394Mn; PAT more than doubled to ₹3,564Mn, driven by margin expansion.

Outlook

Management guided for 25% revenue growth in FY27. Ongoing expansion in high-growth verticals like Battery Chemicals.

Risks

Potential risks include semiconductor business volatility and global pharmaceutical regulatory shifts mentioned in safe harbor.

Source

Earnings Call filed with BSE, NSE: ACUTAAS. Summary written with AI assistance from the document.

Read the document ↗

Acutaas Chemicals Ltd: key numbers

Share price
₹3,272.50
Market cap
₹26,792 Cr
Revenue (annual)
₹1,339 Cr
Net profit (annual)
₹356.3 Cr
P/E (TTM)
69.4×Sector 50.4×
Promoter holding
32.66%+0.00% QoQ
FII holding
21.61%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Acutaas Chemicals Ltd

All →
19:20 IST BSE
Management Change

Acutaas Chemicals Management Change

Acutaas Chemicals Limited has announced the re-appointment of Ram Mohan Lokhande as Executive Director and Anita Bandyopadhyay as Non-Executive Independent Director for a 60-month term.

20:03 IST BSE
Acquisition

Acutaas Chemicals Acquisition Worth ₹0.01 Cr

Acutaas Chemicals will acquire 100% of Enchem Ami Organics Private Limited for Rs. 1 Lakh, making it a wholly owned subsidiary.

Value
₹0.01 Cr
Execution
One month
19:36 IST BSE
Merger & Restructuring

Acutaas Chemicals Merger & Restructuring Worth ₹0.01 Cr

Acutaas Chemicals will acquire 100% equity stake in step-down subsidiary Enchem Ami Organics for Rs. 1 Lakh, making it a direct wholly-owned subsidiary.

Value
₹0.01 Cr
Execution
within one month
17:22 IST BSE
Annual General Meeting

Acutaas Chemicals Annual General Meeting

Acutaas Chemicals Limited conducted its 19th Annual General Meeting on September 24, 2026, where shareholders transacted various ordinary and special business items.

17:59 IST BSE
Patent

Acutaas Chemicals Patent

Acutaas Chemicals Limited has received a patent from the Indian Patent Office for a process to prepare 2,4-dimethylthiophenol. The company now holds 11 patents.

12:04 IST BSE
Capacity Expansion

Acutaas Chemicals Capacity Expansion

Acutaas Chemicals Limited inaugurated a new state-of-the-art Pilot Plant at Unit 1 in Sachin, Surat. The facility supports R&D for high potency active pharmaceutical ingredients.

pilot plant
1.0 plants